Dr. Ladan Teimoori-Toolabi Ph.D./ Biotechnology (Pasteur Institute of Iran); Medical Doctor (Tehran University of Medical Sciences)
Professor, Pasteur Institute of Iran, Tehran · Iran
Editorial leadership for Journal of Cancer Genetics And Biomarkers ISSN 2572-3030
Research interests
- Cancer
- Epigenetics
- Drug Design
- Chemotherapeutic Drug Resistance
- Biomarkers
Biography
Dr. Ladan Teimoori-Toolabi is a Professor at the Pasteur Institute of Iran in Tehran, where her research focuses on cancer biology, epigenetics, drug design, chemotherapeutic drug resistance, and biomarker development. She received her PhD from the Pasteur Institute of Iran and completed additional training at Tehran University of Medical Sciences. Her scholarly work encompasses over 19 indexed publications, with her most-cited contribution being "In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6)" (2020), which has garnered 41 citations. Dr. Teimoori-Toolabi's research integrates computational and molecular approaches to advance understanding of cancer mechanisms and therapeutic interventions.
Selected publications
- In-silico identification of new inhibitors for Low-density lipoprotein receptor-related protein6 (LRP6) 2020 cited 41×
- Molecular alterations contributing to pancreatic cancer chemoresistance 2017 cited 40×
- Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAFV600E mutation as biomarkers for papillary thyroid carcinoma 2020 cited 26×
- Oncolytic herpes simplex virus type-1 expressing IL-12 efficiently replicates and kills human colorectal cancer cells 2021 cited 25×
- Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathway 2020 cited 16×
- Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study 2022 cited 16×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCGB for your work?
This journal is guided by Dr. Ladan Teimoori-Toolabi (Professor, Pasteur Institute of Iran, Tehran) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.